Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksSUVEN
resources
SUVEN
373.15-0.5 (-0.12%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Suven Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Suven Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Monitoring Agency Report11 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for the quarter ended 30th June, 2026
  2. Newspaper Publication7 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication- un-audited finacial results
  3. Outcome of Board Meeting6 Aug 2026
    Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026
    Un-audited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026
  4. Newspaper Publication31 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Adv. regarding Notice of 37th Annual General Meeting of the Company and E-voting information
  5. Board Meeting30 Jul 2026
    Board Meeting Intimation for Consideration Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June, 2026
    Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
  6. General30 Jul 2026
    Letter To Shareholders Regarding Annual Report FY 2025-26
    Letter to Shareholders regarding Annual Report FY 2025-26
  7. Business Responsibility and Sustainability Reporting (BRSR)30 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Business Responsibility and Sustainability Report (BRSR) for FY 2025-26
  8. AGM30 Jul 2026
    Notice Of 37Th Annual General Meeting (AGM) Of The Company
    Notice of the 37th Annual General Meeting (AGM) of the Company
  9. Reg. 34 (1) Annual Report30 Jul 2026
    Reg. 34 (1) Annual Report.
    Annual Report 2025-26 and Notice of 37th Annual General Meeting (AGM) of the Company
  10. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201120 Jul 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property and Equity Holdings Pvt Ltd & PACs
  11. Newspaper Publication14 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Special window for Re-Lodgment of transfer requests of Physical shares
  12. Analyst / Investor Meet14 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Interaction with Investors and Analysts
  13. Press Release / Media Release10 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find enclosed News Release of our company
  14. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg 74 (5) of SEBI (DP) Regulations, 2018
  15. General8 Jul 2026
    Revised Outcome Of The Meeting Of Board Of Directors- Incorporation Of Wholly Owned Subsidiary (WOS) In Singapore
    Revised outcome of the meeting of Board of Directors - Incorporation of Wholly owned Subsidiary (WOS) in Singapore
  16. General8 Jul 2026
    Incorporation Of Wholly Owned Subsidiary (WOS) In Singapore
    Incorporation of Wholly owned Subsidiary (WOS) in Singapore
  17. Change in Management8 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Re-appointment of Dr. Vajja Sambasiva Rao effective from January 21, 2027 for a second term of 5(five) years
  18. Allotment of Equity Shares8 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment
    Allotment of 18570133 Equity shares of the Company on preferntial basis upon conversion of 18570133 fully paid warrants
  19. Outcome without intimation8 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting
  20. Closure of Trading Window26 Jun 2026
    Closure of Trading Window
    Closure of Trading Window

Frequently Asked Questions

Where can I download the annual report of Suven Life Sciences Ltd.?
Annual reports of Suven Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Suven Life Sciences Ltd.?
Quarterly earnings results and presentations of Suven Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Suven Life Sciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Suven Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Suven Life Sciences Ltd.?
Investor presentations and annual day presentations of Suven Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Suven Life Sciences Ltd.?
Corporate announcements and regulatory filings of Suven Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Suven Life Sciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Suven Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Suven Life Sciences Ltd.?
The ISIN (International Securities Identification Number) of Suven Life Sciences Ltd. is INE495B01038. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Suven Life Sciences Ltd. listed?
Suven Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is SUVEN and the BSE code is -.
Where can I find the shareholding pattern of Suven Life Sciences Ltd.?
The quarterly shareholding pattern of Suven Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Suven Life Sciences Ltd. on Sharpely?
Share price data for Suven Life Sciences Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.